ABSTRACT
Background: The advancing etiopathogenesis, diagnosis, and treatment of the global coronavirus disease 2019 (COVID-19) pandemic have prompted the medical community to consider Ayurveda, Siddha, and Unani as add-on preventive and therapeutic options. Objective: To explore the effect of standalone or integrative Traditional Formulations (TFs) on selected clinical symptoms and biomarkers of COVID-19. Search strategy: Out of 465 articles identified from PubMed, ScienceDirect, and Scopus, 17 randomized controlled trials (RCTs) with 1646 COVID-19 patients published from January 2020 to February 2022 were included in the study. Inclusion criteria: RCTs that compared the effect of standalone/integrative TFs in decoction, tablet, and powder forms with placebo plus standard care (SC)/placebo/SC as controls involving mild to severe symptomatic COVID-19 patients were included. Data extraction and analysis: Three reviewers independently assessed the titles and abstracts of each article based on the inclusion after deleting duplicates. The relevant full texts were retrieved and examined, and then their data were extracted and double-checked by three independent reviewers using prepared data extraction forms. The primary outcome variables were reverse transcription polymerase chain reaction, fever, cough, dyspnea, myalgia, headache, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and D-dimer. Results: The effect of different TFs or integrative TFs was more to inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) than the controls. There was an increase in fever and cough, a decrease in dyspnea, myalgia, headache, and ESR, no change in CRP, and a slight increase in D-dimer as an effect of TFs. Conclusions: Integrative or standalone TF may be the inexpensive preventive and therapeutic option to inhibit SARS-CoV-2 and its clinical symptoms.
ABSTRACT
The discussions on conceptualization, operationalization, measures, and means of well-being (WB) and personal excellence (PE) are dynamic and debatable. Therefore, this study aims to coin a perspective of PE based on the Patanjali Yoga Sutra (PYS). For this, professional, psychological, philosophical, and yogic perspectives of WB and PE are analyzed to derive a viable yogic framework for PE. The WB and the consciousness-based constructs of PE are discussed in terms of psychic tensions (PTs) (nescience, egoism, attachment, aversion, and love for life), yogic hindrances (YHs) (illness, apathy, doubt, procrastination, laziness, over somatosensory indulgence, delusion, inability, and unstable progress), psychosomatic impairments (pain, despair, tremors, arrhythmic breath), and yogic aids (wellness, intrinsic motivation, faith, role punctuality, physical activity, sensory control, clarity, competence, and sustainable progress). The PYS operationalizes PE as the dynamic level of WB and self-awareness until one attains Dharmamegha Samadhi (super consciousness). Lastly, Ashtanga Yoga (AY) is discussed as a universal principle, process, and practice for thinning PTs, vanishing YHs, empowering holistic WB, awakening extrasensory potentials, advancing self-awareness, and PE. This study will be a pioneering base for further observational and interventional studies to develop measures and personalized protocols for PE.
ABSTRACT
The relation between spirituality and health has been argued for decades. The study aimed to ascertain the extent and nature of the relationship between spirituality quantified in terms of Spiritual Intelligence (SI) and distress in ascetics. Sixty-three Hindu ascetics aged 31.3 ± 6.6 years were sampled from Patanjali Yogpeeth, India. Participants' distress and spiritual levels were measured by using the Cornell Medical Index Health Questionnaires (CMHIQs) and Spiritual Intelligence Self-Report Inventory-24 (SISRI-24), respectively. Multiple regression analyses showed an insignificant negative relationship between SI and distress implying SI as a predictor of psychosomatic health.